#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
CS
proLékaře.cz / Journals / Diabetes and obesity / 2024 - 1

Editorial

Czech version

Published in: Diab Obez 2024; 24(1): 3
Category: Editorial

Labels
Diabetology Obesitology
Early use of SGLT2-inhibitors i in the treatment of type 2 diabetes mellitus
Integration of glycemic compensation markers, including glycemic variability in patients with diabetes mellitus
Metformin in the treatment of type 2 diabetes mellitus and its current position
Inklisiran and its role in lipid-lowering therapy
Slovak Diabetes Society recommendations for diabetes education
Type 2 diabetes mellitus and obesity – dangerous companions
Coexistence of SGLT2 inhibitors and GLP-1 receptor agonists in the treatment of a patient with type 2 diabetes mellitus
Current position of GLP-1 receptor agonists in type 2 diabetes mellitus treatment
Long-term sustainability of metabolic compensation in telemedicine use – results of 18 months follow-up
Diabetic distress from clinical diabetology view
6th National SDS Symposium: Where are we moving with technology in diabetology in Slovakia?
Pilot project for early detection of hyperglycemia, prediabetes and/or diabetes mellitus in insured persons of VšZP, a.s., and throughout Slovakia in specialist outpatient clinics of diabetologists in diabetes-naïve patients: report
Advanced Technologies & Treatments for Diabetes 2024, Florencia – sumár z kongresu
Diabetics from all over Slovakia on reconditioning stays
Article was published in

Diabetes and obesity

Issue 1
2024 Issue 1
Most read in this issue
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#